MedTrace Logo

Prognostic Counselling in Palliative Head and Neck Cancer (ProCoPall)

NCT06699316 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-11-21

No results posted yet for this study

Summary

The investigators test the effect of providing individualized prognostic information on life-expectancy to head and neck cancer patients in the palliative phase.

Conditions

  • Squamous Cell Carcinoma of Head and Neck

Interventions

OTHER

Individualized prognostic counselling

Individualized prognostic counselling on life expectancy using the prognostic model 'OncologIQ Palliative'

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2025-12-31
Completion
2026-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06699316 on ClinicalTrials.gov